Home Communication Press Room Press Releases Stay up-to-date on our communications Print Share RSS Date Min Max Aeronautics Automotive Corporate Cybersecurity Defense and Security Financial Healthcare Industry Intelligent Transportation Systems Digital Public Services Services Space Healthcare La Paz Hospital and GMV work to bring medical imaging technology from outer space to primary care facilities AI can help with medical imaging training and diagnostic accuracy in primary care. Thanks to Alisse, personnel with no medical experience or training produced images of sufficient diagnostic quality nine times out of ten, fairly close to how expert sonographers performed on the same testsThe World Health Organization estimates that 80% of medical decisions are based on diagnostic imagingPrimary care services address over 90% of the reasons for patients’ visits, becoming the gateway to the public healthcare system Healthcare GMV to develop the PMMCare+ platform to facilitate comprehensive, holistic care for patients with multimorbidity It will be working within the framework the European Carematrix project, which seeks to provide innovative solutions that improve the quality of comprehensive treatment for patients with two or more chronic conditions while increasing the efficiency of public healthcare servicesPMMCare+ will provide the technical means needed to coordinate the work of the various teams caring for these patients, as well as to involve these patients in their healthcareCarematrix is expected to achieve the following: a 20% reduction in time spent on visits to healthcare facilities, a 75% improvement in care-related aspects, a 50% reduction in patient data management incidents, and a 30% reduction in clinical errors HealthcareCybersecurity Cybersecurity in Ubiquitous Healthcare and Collaborative Research The liquid hospital, a new patient care model based on e-health, represents a paradigm shift towards more personalized and precise medicine. The challenge in this context is cybersecurity in the interconnection between systems and medical devices inside and outside healthcare centers, as well as ensuring people's privacy In silico research entails modeling, simulating, and visualizing biological and medical processes using computers. This context requires more collaborative research and data sharing for training mathematical models. Federated networks become a key element in ensuring the secure use of data According to the IADB's cybersecurity guide for the healthcare sector, there is an average period of 329 days from a successful cyberattack to the institution’s awareness of its data breach Cybersecurity incident response centers must possess advanced automation systems powered by artificial intelligence models. They need technology that can enhance the organization’s visibility when handling potential security incidents, along with response teams whose work is uniform and traceable Healthcare AI for early detection and prediction of Alzheimer’s disease Analyzing speech can prove to be a valuable tool in predicting the onset of Alzheimer’s disease, according to research conducted using artificial intelligence tools in the TARTAGLIA project Certain aspects of spontaneous language are linked to patients who exhibit an accumulation of beta-amyloid protein in the brain, a defining characteristic of individuals with this form of dementia Healthcare GMV contributes with its technology to disease prevention and adherence to a healthy lifestyle The technological development of MedP-Big Data project is complete. This project aims to improve personalized patient care, health promotion, prevention, and treatment using big data and artificial intelligence (AI) The project will enable the healthcare services in the Canary Islands and Valencia to promote personalized and precision medicine This is an example of a national project whose use cases could be applied to any current healthcare service Healthcare GMV applies artificial intelligence and "Real World Data" for the early detection of prostate cancer It is the second most common type of cancer that affects more than 1.2 million men worldwide and is the third leading cause of cancer death With its technology, GMV facilitates the application of evidence-based personalized medicine, as well as the development of clinical guidelines for the benefit of the patient Together with PIONEER and OPTIMA, the Evidence Hub of the European Association of Urology (EAU) and TARTAGLIA are some examples of GMV's contribution to the fight against prostate cancer Healthcare GMV’s technology is being used at the ToxHub biomedical data platform to improve the safety of pharmaceutical products The direct benefit of ToxHub is that it allows preclinical and clinical databases to be brought together into an integrated data infrastructure, to help increase the efficiency of clinical trials, reduce research times, and achieve better results for toxicity studies The platform is being used to increase the safety of pharmaceuticals, replacing some of the animal research by applying retrospective analysis technology to the evidence compiled by the pharmaceutical industry Healthcare GMV launches health-focused knowledge forum called HealthTech Observer The aim is to accelerate the uptake of digital technologies in areas such as personalized and precision medicine The initiative is aligned with the company’s commitment to the United Nations Sustainable Development Goals (SDGs) and the European Union’s EU4Health program Healthcare system digitalization, system interoperability, the adaptation of processes and procedures to new needs, personalized and precision medicine, humanization or artificial intelligence in healthcare, and the use of big data to set up federated data networks are some of the topics that will be addressed as part of this forum Healthcare Cuídat-e: a Pioneering Personalized Medicine Project Developed with GMV’s Technology The purpose of this Spanish healthcare project is to improve personalized care for patients with chronic illnesses, cancer, and degenerative and rare diseases. It uses tools that assist with clinical decision-making to offer the public a more advanced and efficient healthcare system Cuídat-e is one of the use cases of the Big Data Personalized Medicine project, which has a budget of €5,833,774, including €3,833,774 from the Canary Islands region (85% co‑funded by the Spanish Rare Disease Federation (FEDER), and €2,000,000 from the Valencian Community region (50% co‑funded by FEDER) Healthcare Long-Term Results from the TARGIT-A Clinical Trial Show Significant Improvements for Breast Tumor Treatment with Use of Intraoperative Radiation Therapy In addition, use of the RadianceTM planning system allows estimation of the dose received in at‑risk organs, to help protect them from radiation side effects These results are being published just as the Spanish Cancer Radiation Therapy Society (SEOR) prepares to commemorate the anniversary of the first documented radiotherapy cure Healthcare Digital Technology and Big Data are Advancing Personalized Treatments for Blood Cancer Patients Almost 120,000 anonymized data records have already been identified for patients with hematologic malignancies. Research is now being focused on finding the most effective therapies that can cover the entire research spectrum for these forms of cancer, bringing new hope for those suffering from the less common types GMV is the technological partner responsible for the secure platform that stores the data and makes it available for scientific analysis, with anonymization of the data and harmonization based on the common OMOP data model HealthcareSpace ESA relies on GMV to monitor the health of astronauts The multinational firm is working on a solution to assist with the diagnosis of crew members while reducing the need for consultation with physicians on Earth The project will enhance the use of ultrasound technology to capture clinically relevant medical images of the astronauts’ organs Pagination Current page 1 Page 2 Next page › Last page »